A federal directive aimed at securing agricultural chemicals has triggered bipartisan scrutiny and renewed arguments over pesticide safety and liability protections.
By yourNEWS Media Newsroom
Donald Trump issued an executive order in February invoking the Defense Production Act to increase domestic production of a key chemical used in herbicides, setting off a nationwide debate over food security, public health and legal accountability.
The order identifies elemental phosphorus as a critical component in the production of glyphosate-based herbicides, describing such products as essential to maintaining U.S. agricultural output. According to the directive, these herbicides are “the most widely used crop protection tools in the United States” and a “cornerstone” of the nation’s farming efficiency and rural economy.
Supporters of the policy argue that access to herbicides is necessary to sustain large-scale farming operations and protect the country’s food supply. Industry advocates have warned that ongoing litigation over alleged health risks—particularly claims linking glyphosate to cancer—could disrupt production and limit availability of essential agricultural inputs.
Critics, however, say the order could provide legal protections to manufacturers of herbicides such as Roundup, raising concerns about reduced accountability. Health advocate Leah Wilson, who leads the nonprofit Stand for Health Freedom, warned that expanded immunity for pesticide producers could have long-term consequences.
“What if I told you that there’s a coordinated effort to stop food reform in the US and that effort is being carried out by the big chemical industry to make sure that they don’t lose their market share of the food market?” Wilson said in an interview with Full Measure.
Wilson compared the current push for liability protections to the framework established under the National Childhood Vaccine Injury Act of 1986, which significantly limits legal claims against vaccine manufacturers. She said such protections led to increased vaccine use while restricting legal recourse for alleged injuries.
Industry representatives have argued that similar protections for pesticide manufacturers are necessary to prevent litigation from undermining agricultural productivity. They contend that herbicides play a critical role in crop management and that restricting their use could raise costs and reduce yields.
The environmental and health concerns center on glyphosate, the active ingredient in many herbicides. The U.S. Environmental Protection Agency has maintained that glyphosate is safe when used according to label directions and does not require cancer warnings. However, manufacturers have faced extensive litigation, including a proposed $7.25 billion class-action settlement addressing current and future cancer claims, along with more than $11 billion already paid in previous cases.
Legal analysts say the executive order does not provide blanket immunity but may shield companies from certain liabilities when acting in compliance with federal directives. The extent of that protection remains unclear and could be subject to court interpretation.
Opposition to the policy has emerged from both political parties. A bipartisan group in Congress is working to reverse or limit the order, aiming to preserve the ability of individuals to pursue legal claims against pesticide manufacturers.
The dispute reflects broader tensions between agricultural policy, public health concerns, and regulatory oversight, as federal officials, lawmakers, and advocacy groups continue to debate how to balance food production needs with safety and accountability measures.